WT1 and ovarian carcinoma: Furthermore, the inhibition of the Wilms tumour 1 (WT1) gene, overexpressed in ovarian carcinoma but not in normal tissue, by an antisense oligodeoxynucleotide (ASODN) delivered in liposomes, led to the inhibition of ovarian cancer cell proliferation, cell cycle arrest, and increased apoptosis in vitro [71].